Marino The ICU Book 4e, IE


Disorders of Consciousness

23. Kunze K. Metabolic encephalopathies. J Neurol 2002; 249:1150–1159. 24. Wijdicks EFM. Neurologic manifestations of pharmacologic agents commonly used in the intensive care unit. In: Neurology of critical illness. Philadelphia: F.A. Davis, Co., 1995:3–17. 25. Teasdale G, Jennett B. Assessment of coma and impaired consciousness. A practical scale. Lancet 1974; 2:81–84. 26. Teasdale G, Jennett B. Assessment and prognosis of coma after head injury. Acta Neurochir (Wien) 1976; 34:45–55. 27. Sacco RL, VanGool R, Mohr JP, et al. Nontraumatic coma. Glasgow coma score and coma etiology as predictors of 2-week outcome. Arch Neurol 1990; 47:1181–1184. Brain Death 28. Uniform Determination of Death Act, 12 uniform laws annotated 589 (West 1993 and West suppl 1997). 29. Smith AJ, Walker AE. Cerebral blood flow and brain metabolism as indica- tors of cerebral death. A review. Johns Hopkins Med J 1973; 133:107–119. 30. The Quality Standards Subcommittee of the American Academy of Neur- ology. Practice parameters for determining brain death in adults (summary statement). Neurology 1995; 45:1012–1014. 31. Wijdicks EFM, Varelas PNV, Gronseth GS, Greer DM. Evidence-based guideline update: determining brain-death in adults. Report of the Quality Standards Sub- committee of the AmericanAcademy of Neurology. Neurology 2010; 74:1911–1918. 32. Wijdicks EF. The diagnosis of brain death. N Engl J Med 2001; 344:1215–1221. 33. Dominguez-Roldan JM, Barrera-Chacon JM, Murillo-Cabezas F, et al. Clinical factors influencing the increment of blood carbon dioxide during the apnea test for the diagnosis of brain death. Transplant Proc 1999; 31:2599–2600. 34. Goudreau JL, Wijdicks EF, Emery SF. Complications during apnea testing in the determination of brain death: predisposing factors. Neurology 2000; 55:1045–1048. 35. Ropper AH. Unusual spontaneous movements in brain-dead patients. Neurology 1984; 34:1089–1092. The Potential Organ Donor 36. Wood KE, Becker BN, McCartney JG, et al. Care of the potential organ donor. N Engl J Med 2004; 351:2730–2739. 37. Detterbeck FC, Mill MR. Organ donation and the management of the multi- ple organ donor. Contemp Surg 1993; 42:281–285. 38. Guesde R, Barrou B, Leblanc I, et al. Administration of desmopressin in brain- dead donors and renal function in kidney recipients. Lancet 1998; 352:1178–1181. A FinalWord 39. Fallowfield LJ, Jenkins VA, Beveridge HA. Truth may hurt but deceit hurts more: communication in palliative care. Palliative Med 2002; 16:297–303.

Made with